• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Non-palpable invasive breast carcinomas from the Stockholm screening project.

作者信息

von Rosen A, Frisell J, Glas U, Hellström L, Nilsson R, Skoog L, Auer G

机构信息

Department of Surgery, Sodersjukhuset, Stockholm, Sweden.

出版信息

Acta Oncol. 1989;28(1):23-7. doi: 10.3109/02841868909111176.

DOI:10.3109/02841868909111176
PMID:2706131
Abstract

Sixty-six non-palpable, invasive mammary adenocarcinomas from the Stockholm mammography screening project were studied with respect to histopathology. In 53 of these tumors estrogen receptor (ER) content was estimated and in 30 of them also the DNA distribution pattern. The tumors were predominantly of low or intermediate histological malignancy grade and ER-rich, whereas the distribution of DNA ploidy equalled that found in a non-selected tumor material. Only 2 tumors recurred during follow-up (median 51 months), indicating that non-palpable breast carcinomas represent a prognostically favourable subset in spite of a relatively high proportion of aneuploid tumors.

摘要

相似文献

1
Non-palpable invasive breast carcinomas from the Stockholm screening project.
Acta Oncol. 1989;28(1):23-7. doi: 10.3109/02841868909111176.
2
Cytophotometrical and biochemical characterization of nonpalpable, mammographically detected mammary adenocarcinomas.乳腺钼靶检测到的不可触及性乳腺腺癌的细胞光度学和生化特征
Cytometry. 1984 Jul;5(4):426-9. doi: 10.1002/cyto.990050421.
3
DNA ploidy in screening-detected non-palpable mammary carcinomas.筛查发现的不可触及性乳腺癌中的DNA倍体
Eur J Surg Oncol. 1990 Dec;16(6):471-4.
4
Prognostic value of nuclear DNA content in breast cancer in relation to tumor size, nodal status, and estrogen receptor content.乳腺癌细胞核DNA含量与肿瘤大小、淋巴结状态及雌激素受体含量的预后价值。
Breast Cancer Res Treat. 1989 Jan;13(1):23-32. doi: 10.1007/BF01806547.
5
Nuclear DNA content, histological grade, and clinical course in patients with nonpalpable mammographically detected breast adenocarcinomas.乳腺钼靶检查发现的不可触及乳腺腺癌患者的核DNA含量、组织学分级及临床病程
Am J Clin Oncol. 1990 Feb;13(1):23-7. doi: 10.1097/00000421-199002000-00007.
6
Histopathologic and cytochemical characteristics of interval breast carcinomas from the Stockholm Mammography Screening Project.来自斯德哥尔摩乳腺钼靶筛查项目的间期乳腺癌的组织病理学和细胞化学特征
Acta Oncol. 1992;31(4):399-402. doi: 10.3109/02841869209088278.
7
Relationship between nuclear DNA distribution and estrogen receptors in human mammary carcinomas.人类乳腺癌中核DNA分布与雌激素受体之间的关系。
Anal Quant Cytol. 1980 Dec;2(4):280-4.
8
Relationship between certain radiographic and biologic characteristics in breast cancer.
Acta Oncol. 1987;26(2):89-93. doi: 10.3109/02841868709091746.
9
[The treatment of non-palpable breast tumors found during mammographic screening at our hospital].[我院乳腺钼靶筛查中发现的不可触及乳腺肿瘤的治疗]
Magy Seb. 2005 Jun;58(3):162-6.
10
Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.女性乳腺原位癌。一项临床病理、免疫组织化学及DNA倍体研究。
APMIS Suppl. 2003(108):1-67.

引用本文的文献

1
Screening for breast cancer with mammography.通过乳房X线摄影术筛查乳腺癌。
Cochrane Database Syst Rev. 2013 Jun 4;2013(6):CD001877. doi: 10.1002/14651858.CD001877.pub5.